To further explore the requirement of CD4 and/or CD8 T cells for overall mPD1-Fc-OX40L anti-tumor efficacy tumor studies were conducted in mice wherein CD4+ cells, CD8+ cells, or both populations were depleted using monoclonal antibodies.. Here, CD4 is linked to neoplasm.